Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ

$11.26

$+0.50

(+4.69%)

Regular Market

Monte Rosa Therapeutics, Inc. (GLUE) Live Price Chart

Last updated: ⁦2026-10-20 18:07:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Monte Rosa Therapeutics, Inc. (GLUE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $11.26, with a market capitalization of $830.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.94 to $25.77. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$830.95M
Open	$10.72
Day's High	$45.56
Day's Low	$2.44
Previous Close	$10.66
Volume	859.10K
Average Volume	1.38M
P/E Ratio	--
52-Week High	$25.77
52-Week Low	$8.94
Dividend Yield	--
Earnings Date	--

Monte Rosa Therapeutics, Inc. (GLUE) Stock Price Today

Monte Rosa Therapeutics, Inc. (GLUE) is currently trading at $11.26 as of 2026-10-20 18:05:00, up 5.58% ($0.60) from the previous close of $10.66

During today's regular trading session, GLUE has traded between $2.44 and $45.56, with a trading volume of 859.10K shares. The current price is near the lower end of today's range.

Monte Rosa Therapeutics, Inc. (GLUE) 7-Day Stock Price Change

Over the past seven days, Monte Rosa Therapeutics, Inc. (GLUE) moved from $10.30 to $11.26, representing a gain of 9.27% ($0.96).

The stock traded between $9.71 and $11.41 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.64 million shares, down versus the previous seven-day period, indicating lower trading activity.

GLUE 52-Week Price Position

Position in Range: 13.7%

52W Low$8.94

52W High$25.77

GLUE is currently trading at $11.26, placing it 13.7% of the way from its 52-week low of $8.94 to its 52-week high of $25.77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Monte Rosa Therapeutics, Inc. (GLUE)?

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Monte Rosa Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	173
Exchange	NASDAQ
Company Website	https://www.monterosatx.com

How to Buy Monte Rosa Therapeutics, Inc. (GLUE) Stock on MEXC

Eligible investors can buy real shares of Monte Rosa Therapeutics, Inc. (GLUE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GLUE and Place Your Order

Open the RealStocks trading page and search for GLUE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Monte Rosa Therapeutics, Inc. (GLUE) stock price today?

Monte Rosa Therapeutics, Inc. (GLUE) is currently trading at $ 11.26, up 5.58% ($0.60) from the previous close of $ 10.66. Intraday prices update in real time during regular trading hours.

2.Is GLUE stock going up or down today?

As of 2026-10-20 18:05:00, GLUE is trading at $ 11.26, up 5.58% ($0.60) from its previous close of $ 10.66. The stock has traded between $ 2.44 and $ 45.56 during today’s regular session. Past price movements do not guarantee future results.

3.What is GLUE pre-market price?

As of 2026-10-20 18:05:00, GLUE is trading at $ 10.57 in pre-market trading, down 0.84% ($0.09) from the previous close of $ 10.66. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GLUE after-hours price?

As of 2026-10-20 18:05:00, GLUE is trading at $ 10.68 in after-hours trading, up 0.14% ($0.02) from the regular-session close of $ 10.66. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GLUE stock trading now?

GLUE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GLUE sit relative to its 52-week high and low?

Over the past 52 weeks, GLUE has traded between a low of $ 8.94 and a high of $ 25.77. At $ 11.26, the stock is positioned 13.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Monte Rosa Therapeutics, Inc. in?

Monte Rosa Therapeutics, Inc. (GLUE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Monte Rosa Therapeutics, Inc.'s market capitalization and where is it listed?

Monte Rosa Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 830.95M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GLUE valued in terms of P/E ratio and EPS?

GLUE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Monte Rosa Therapeutics, Inc. pay a dividend?

Monte Rosa Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.